Literature DB >> 18815819

NF1 diagnosis criteria and associated sarcomatous tumor review of the literature and case report.

Márcia Gaiger de Oliveira1, Sabrina Pozatti Moure, Paulo Sérgio Batista, Anna Cecília Moraes Chaves, Pantelis V Rados, Manoel Sant'Ana Filho.   

Abstract

AIM: This paper reports the case of a sarcomatous tumor (probably a pleomorphic sarcoma) in a patient with Neurofibromatosis type 1 (NF1) and discusses the association between these two diseases.
BACKGROUND: NF1 is an autosomal dominant tumor predisposition syndrome. Malignant transformation is observed in patients with this disease, usually in the form of malignant peripheral nerve sheath tumors (MPNSTs). REPORT: A 72-year-old female patient with diagnosis of NF1 presented with left mandibular region enlarged for about 6 months, intra-oral examination revealed a mass growth on the floor of the lower left posterior area of the oral cavity measuring 5 cm in its greatest diameter and covered by ulcerated mucosa.
SUMMARY: Few cases of association of neurofibromatosis with other types of soft tissue sarcomas have been reported. Undifferentiated pleomorphic sarcomas are the most common of these tumors. We intend to call attention to the importance of patient follow-up and counseling.

Entities:  

Mesh:

Year:  2008        PMID: 18815819     DOI: 10.1007/s10006-008-0137-1

Source DB:  PubMed          Journal:  Oral Maxillofac Surg        ISSN: 1865-1550


  17 in total

Review 1.  Malignant fibrous histiocytoma of soft tissue: an abandoned diagnosis.

Authors:  R Lor Randall; Karen H Albritton; Brandon J Ferney; Lester Layfield
Journal:  Am J Orthop (Belle Mead NJ)       Date:  2004-12

Review 2.  The diagnostic evaluation and multidisciplinary management of neurofibromatosis 1 and neurofibromatosis 2.

Authors:  D H Gutmann; A Aylsworth; J C Carey; B Korf; J Marks; R E Pyeritz; A Rubenstein; D Viskochil
Journal:  JAMA       Date:  1997-07-02       Impact factor: 56.272

3.  Association between benign and malignant peripheral nerve sheath tumors in NF1.

Authors:  T Tucker; P Wolkenstein; J Revuz; J Zeller; J M Friedman
Journal:  Neurology       Date:  2005-07-26       Impact factor: 9.910

Review 4.  Classification of pleomorphic sarcomas: where are we now?

Authors:  A P Dei Tos
Journal:  Histopathology       Date:  2006-01       Impact factor: 5.087

5.  Risk of malignancy and death in neurofibromatosis.

Authors:  M Poyhonen; S Niemela; R Herva
Journal:  Arch Pathol Lab Med       Date:  1997-02       Impact factor: 5.534

6.  A rare case of malignant fibrous histiocytoma of the gingiva.

Authors:  Rupali Agnihotri; K Mahalinga Bhat; G Subraya Bhat
Journal:  J Periodontol       Date:  2008-05       Impact factor: 6.993

7.  Neurofibromatosis: oral and radiographic manifestations.

Authors:  S D Shapiro; K Abramovitch; M L Van Dis; L J Skoczylas; R P Langlais; R J Jorgenson; R S Young; V M Riccardi
Journal:  Oral Surg Oral Med Oral Pathol       Date:  1984-10

8.  Oral undifferentiated high-grade pleomorphic sarcoma: report of a case.

Authors:  Edson Alfredo; Joubert Magalhães de Pádua; Eduardo Luis Vicentini; Melissa Andreia Marchesan; Raphael Carlos Comelli Lia; Danyel Elias da Cruz Perez; Yara Teresinha Corrêa Silva-Sousa
Journal:  Oral Surg Oral Med Oral Pathol Oral Radiol Endod       Date:  2008-01

9.  Association of soft tissue sarcomas other than neurofibrosarcoma with neurofibromatosis.

Authors:  R Southcott; H H Lucraft
Journal:  Clin Oncol (R Coll Radiol)       Date:  2002-10       Impact factor: 4.126

10.  Mandibular abnormalities in neurofibromatosis. Case report and literature review.

Authors:  S D Vincent; T P Williams
Journal:  Oral Surg Oral Med Oral Pathol       Date:  1983-03
View more
  2 in total

1.  Epithelioid sarcoma associated with neurofibromatosis type I.

Authors:  Sung Oh Hwang; Soo Hyang Lee; Han Byul Lee
Journal:  Arch Craniofac Surg       Date:  2020-02-20

2.  Type I neurofibromatosis with spindle cell sarcoma: A case report.

Authors:  Yu Zhang; Jiao-Jiao Chao; Xiu-Feng Liu; Shu-Kui Qin
Journal:  World J Clin Cases       Date:  2019-10-06       Impact factor: 1.337

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.